share_log

Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results

SEC announcement ·  Feb 6 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more